Haemonetics shares rise on CSL rollout target
CSL Plasma expects to complete the rollout of Haemonetics devices and disposables under their supply agreement by end-2027, after which Haemonetics shares rose in premarket.
CSL Plasma expects to complete the rollout of Haemonetics devices and disposables under their supply agreement by end-2027, after which Haemonetics shares rose in premarket.